The Drugs Controller General of India has approved the commercial launch of 'Feluda', the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of Scientific and Industrial Research (CSIR) said on Saturday.from IndiaTV India: Google News Feed https://ift.tt/2EkOtJW
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.